DrugPatentWatch Database Preview
DrugPatentWatch Database Updates: New Patent Additions
» See Plans and Pricing
DrugPatentWatch Database Updates: New Patent Additions
Applicant | Tradename | Generic Name | Dosage | NDA | Number | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist Requested | Patent Expiration | Date Submitted | Usecode | Patented / Exclusive Use |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sarepta Theraps Inc | EXONDYS 51 | eteplirsen | SOLUTION | 206488 | 001 | Sep 19, 2016 | RX | Yes | Start Trial | Y | Start Trial | 2019-12-18 | ||||
Sarepta Theraps Inc | EXONDYS 51 | eteplirsen | SOLUTION | 206488 | 002 | Sep 19, 2016 | RX | Yes | Start Trial | Y | Start Trial | 2019-12-18 | ||||
Pfizer | IBRANCE | palbociclib | TABLET | 212436 | 001 | Nov 1, 2019 | RX | Yes | Start Trial | Y | Y | Start Trial | 2019-11-26 | |||
Pfizer | IBRANCE | palbociclib | TABLET | 212436 | 002 | Nov 1, 2019 | RX | Yes | Start Trial | Y | Y | Start Trial | 2019-11-26 | |||
Pfizer | IBRANCE | palbociclib | TABLET | 212436 | 003 | Nov 1, 2019 | RX | Yes | Start Trial | Y | Y | Start Trial | 2019-11-26 | |||
Eiger Biopharms | ZOKINVY | lonafarnib | CAPSULE | 213969 | 001 | Nov 20, 2020 | RX | Yes | Start Trial | Start Trial | 2021-02-24 | U-3070 | REDUCING THE RISK OF MORTALITY IN HUTCHINSON-GILFORD PROGERIA SYNDROME (HGPS) | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Number | >Approval Date | >Type | >RLD | >Patent No. | >Product | >Substance | >Delist Requested | >Patent Expiration | >Date Submitted | >Usecode | >Patented / Exclusive Use |